MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo

导出原文传递

翻译打印收藏纠错

作者： Ulasov, Ilya ^[1] ; Borovjagin, Anton V. ^[2] ; Kaverina, Natalya ^[3] ; Schroeder, Brett ^[4] ; Shah, Nameeta ; Lin, Biaoyang ; Baryshnikov, Anatoly ; Cobbs, Charles

作者单位： Swedish Neurosci Inst, Ctr Adv Brain Tumor Ctr, Seattle, WA 98122 USA ^[1] Univ Alabama Birmingham, Inst Oral Hlth Res, Sch Dent, Birmingham, AL 35205 USA ^[2] Michigan State Univ, Coll Med, Grand Rapids, MI 49503 USA ^[3] NN Blokhin Canc Res Ctr RONC, Lab Expt Diagnost & Biotherapy, Moscow 123481, Russia ^[4]

关键词 Brain tumor Adenovirus Glioma Metalloproteinase

发布时间 2015-09-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer letters

2015年365卷2期

240-250页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo

Cancer letters

相似文献

Cancer letters

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo

Cancer letters

相似文献

Cancer letters

相关期刊

检索历史清除